An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors market the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting products of unknown origin.
Several experts said the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Response and Content Elimination
According to the social media company, the service has removed problematic content and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Digital Trading Operations
Research also found groups with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
Within minutes of entering one group, a seller shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or previous experience.
Item Details and Pricing
Inside these communities, posts show black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering substances they can’t verify. Although the research behind this drug is valid, these digital products may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her team has previously seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to potentially significant health risks”.
